Biocardia Inc. -CW22BCDAWPreferred / convertible
13F holders, Q2 2024 (June 30)7holders +3
3new positions
0sold out
1famous investor
$0.01avg. 13F price*
At the end of Q2 2024, 7 institutions reported holding Biocardia Inc. -CW22 (BCDAW) in their 13F filings, up 3 from Q1 2024. 3 opened new positions and 0 sold out. The largest holders were Citadel Advisors ($745), Susquehanna International Group, LLP ($341) and GenTrust, LLC ($196). One famous investor held it Ken Griffin ( of Citadel Advisors's portfolio).
- Company
- Biocardia Inc. -CW22
- CUSIP
- 09060U119
- Latest filing quarter
- Q2 2024
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $472 |
| Exits | 0 | $0 |
All 13F filers, Q1 2024 → Q2 2024: 51,728 shares bought and 21,030 shares sold, net +30,698 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 7 holders
| Citadel Advisors | — | Add +33.7% | 58,644 | $745 |
| Susquehanna International Group, LLP | — | New | 26,827 | $341 |
| GenTrust, LLC | — | No change | 15,293 | $196 |
| UBS Group AG | — | New | 10,030 | $130 |
| Osaic Holdings, Inc. | — | Reduce -68.8% | 9,560 | $95 |
| Bank of America Corp. | — | No change | 5,735 | $69 |
| Clear Street LLC | — | New | 100 | $1 |
"% of holder's portfolio" is BCDAW's weight in each manager's 13F, not the share of Biocardia Inc. -CW22 the manager owns.